Management of malignant germ cell tumours of ovary. 1992

R Tandon, and L Kumar, and A Vaid, and V Kochupillai, and S Kumar, and A Kriplani, and V L Bhargava
Institute of Medical Sciences, Banaras Hindu University, Varanasi.

Ten patients of the advanced malignant germ cell tumours of the ovary were treated by cisplatin based combination chemotherapy after initial conservation surgery. Eight patients completed course containing cisplatinum, vinblastine and bleomycin. Five patients (62.5%) achieved CR while 2 (25%) attained PR. One patient died due to tumour lysis and respiratory infection. Rest two patients did not turn up in follow up. Long term follow up indicates above regimen to be highly effective. However poor performance status, advanced stage of disease and post operative gross residual disease were poor prognostic factors in our patients.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D009373 Neoplasms, Germ Cell and Embryonal Neoplasms composed of primordial GERM CELLS of embryonic GONADS or of elements of the germ layers of the EMBRYO, MAMMALIAN. The concept does not refer to neoplasms located in the gonads or present in an embryo or FETUS. Germ Cell Cancer,Germ Cell Tumor,Neoplasms, Embryonal and Mixed,Cancer, Embryonal,Cancer, Embryonal and Mixed,Embryonal Neoplasms,Germ Cell Neoplasms,Germ Cell and Embryonal Neoplasms,Germ Cell and Embryonic Neoplasms,Neoplasms, Embryonal,Neoplasms, Germ Cell,Neoplasms, Germ Cell and Embryonic,Cancer, Germ Cell,Cancers, Embryonal,Cancers, Germ Cell,Embryonal Cancer,Embryonal Cancers,Embryonal Neoplasm,Germ Cell Cancers,Germ Cell Tumors,Neoplasm, Embryonal,Tumor, Germ Cell,Tumors, Germ Cell
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D001761 Bleomycin A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. BLEO-cell,Blanoxan,Blenoxane,Bleolem,Bleomicina,Bleomycin A(2),Bleomycin A2,Bleomycin B(2),Bleomycin B2,Bleomycin Sulfate,Bleomycins,Bleomycinum Mack,Bléomycine Bellon,BLEO cell,BLEOcell,Bellon, Bléomycine,Mack, Bleomycinum,Sulfate, Bleomycin
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R Tandon, and L Kumar, and A Vaid, and V Kochupillai, and S Kumar, and A Kriplani, and V L Bhargava
June 2011, Gynecologic oncology,
R Tandon, and L Kumar, and A Vaid, and V Kochupillai, and S Kumar, and A Kriplani, and V L Bhargava
April 2007, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico,
R Tandon, and L Kumar, and A Vaid, and V Kochupillai, and S Kumar, and A Kriplani, and V L Bhargava
April 1998, Seminars in oncology,
R Tandon, and L Kumar, and A Vaid, and V Kochupillai, and S Kumar, and A Kriplani, and V L Bhargava
September 2006, Current opinion in oncology,
R Tandon, and L Kumar, and A Vaid, and V Kochupillai, and S Kumar, and A Kriplani, and V L Bhargava
August 1995, Gan to kagaku ryoho. Cancer & chemotherapy,
R Tandon, and L Kumar, and A Vaid, and V Kochupillai, and S Kumar, and A Kriplani, and V L Bhargava
June 2012, Best practice & research. Clinical obstetrics & gynaecology,
R Tandon, and L Kumar, and A Vaid, and V Kochupillai, and S Kumar, and A Kriplani, and V L Bhargava
May 1982, British medical journal (Clinical research ed.),
R Tandon, and L Kumar, and A Vaid, and V Kochupillai, and S Kumar, and A Kriplani, and V L Bhargava
February 1982, British medical journal (Clinical research ed.),
R Tandon, and L Kumar, and A Vaid, and V Kochupillai, and S Kumar, and A Kriplani, and V L Bhargava
February 1987, Harefuah,
R Tandon, and L Kumar, and A Vaid, and V Kochupillai, and S Kumar, and A Kriplani, and V L Bhargava
January 2000, Forum (Genoa, Italy),
Copied contents to your clipboard!